Table 2.
Traditional respiratory | Intervention endocrinology | Percentage of rate reduction (95% CI)a | P-value | |
---|---|---|---|---|
Patient-days | 2315 | 2467 | ||
Preventable adverse events, n (rateb) | 5 (2.2) | 4 (1.6) | −27.3 (−85.1 to 249) | 0.68 |
Intercepted potential adverse events, n (rate) | 16 (6.9) | 3 (1.2) | −82.6 (−97.7 to −38.5) | 0.002 |
Non-intercepted potential adverse events, n (rate) | 56 (24.2) | 41 (16.6) | −31.4 (−55.2 to 4.6) | 0.067 |
Minor errors, n (rate) | 18 (7.8) | 20 (8.1) | 3.8 (−52.2 to 91.0) | 0.90 |
Overall, n (rate) | 95 (41.0) | 68 (27.6) | −32.7 (−52.9 to −10.4) | 0.006 |
aRate reduction = (rate of Endocrine – rate of Respiratory) × 100/rate of Respiratory.
bRate is expressed as number (per 1000 patient-days).